Table 2.
Univariate Analysis of Survival.
| DFS | OS | |||||
|---|---|---|---|---|---|---|
| Variables | P Value | HR | 95%CI | P Value | HR | 95%CI |
| Gender (male, female) | .558 | 1.123 | 0.761-1.659 | .444 | 0.826 | 0.506-1.348 |
| Age (≤ge, >60) | .558 | 0.890 | 0.603-1.314 | .595 | 0.888 | 0.572-1.378 |
| Smoking (yes, no) | .446 | 1,157 | 0.782-1.713 | .179 | 1.369 | 0.866-2.162 |
| Sur (lobe, non-lobe) | .040 | 1.472 | 1.018-2.129 | .131 | 1.347 | 0.915-1.982 |
| T status (T1, T2/T3) | .314 | 1.141 | 0.883-1.473 | .895 | 1.103 | 0.833-1.233 |
| N status (N0,N1/N2) | .000 | 1.505 | 1.207-1.877 | .002 | 1.476 | 1.147-1.900 |
| Histology (AD,NAD) | .669 | 0.652 | 0.092-4.639 | .081 | 0.124 | 0.012-1.293 |
| Chemo (≤4, >4) | .002 | 0.865 | 0.789-0.949 | .012 | 0.875 | 0.788-0.971 |
| WBC1 (≤10, >10) | .294 | 1.222 | 0.840-1.787 | .050 | 1.518 | 1.000-2.307 |
| WBC2 (≤7, >7) | .003 | 1.755 | 1.212-2.542 | .000 | 2.728 | 1.766-4.212 |
| LDH (≤250, >250) | .005 | 1.690 | 1.170-2.443 | .001 | 2.083 | 1.368-3.173 |
| PLT (≤300, >300) | .097 | 1.377 | 1.944-2.008 | .112 | 1.414 | 0.922-2.170 |
| Hb (≤140, >140) | .048 | 1.829 | 1.005-3.328 | .073 | 1.826 | 0.945-3.527 |
Abbreviations: CI, confidence interval, DFS, disease free survival; HR, hazard ratio; Hb1, preoperative hemoglobin; OS, overall survival; PLT: platelets after adjuvant chemotherapy; WBC1: preoperative white blood cell count, WBC2, white blood cell count after adjuvant chemotherapy.